Group 1 - The core viewpoint of the news is that Meditech experienced a decline in stock price and trading volume, with significant changes in financing and stockholder metrics [1][2]. - On January 6, Meditech's stock fell by 0.65%, with a trading volume of 274 million yuan. The financing buy-in amount was 21.23 million yuan, while the financing repayment was 32.91 million yuan, resulting in a net financing buy of -11.68 million yuan [1]. - As of January 6, the total balance of margin trading for Meditech was 268 million yuan, with a financing balance of 267 million yuan, accounting for 5.71% of the circulating market value, indicating a high level compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Meditech increased to 38,900, a rise of 7.17%, while the average circulating shares per person decreased by 6.69% to 7,864 shares [2]. - For the period from January to September 2025, Meditech reported operating revenue of 22.3 million yuan, a year-on-year decrease of 38.13%, while the net profit attributable to the parent company was 34.27 million yuan, showing a year-on-year increase of 120.49% [2]. - Meditech has cumulatively distributed dividends of 71.36 million yuan since its A-share listing, with no dividends distributed in the last three years [3].

12月29日，麦迪科技盘中下跌5.19%，截至09:35，报15.52元/股，成交8812.63万元，换手率1.84%，总 市值47.54亿元。 资金流向方面，主力资金净流出133.98万元，特大单买入772.20万元，占比8.76%，卖出728.75万元，占 比8.27%；大单买入674.13万元，占比7.65%，卖出851.57万元，占比9.66%。 分红方面，麦迪科技A股上市后累计派现7135.67万元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，麦迪科技十大流通股东中，鹏华碳中和主题混合A（016530）退 出十大流通股东之列。 责任编辑：小浪快报 资料显示，苏州麦迪斯顿医疗科技股份有限公司位于江苏省苏州工业园区归家巷222号，成立日期2009 年8月14日，上市日期2016年12月8日，公司主营业务涉及提供临床医疗管理信息系统(CIS)系列应用软 件和临床信息化的整体解决方案。主营业务收入构成为：自制软件40.39%，运维服务31.55%，医疗服 务21.12%，整体解决方案4.60%，外购软硬件1.95%，其他0.40%。 麦迪科技所属申万行业为：计算机-软件开发-垂直应 ...

融券方面，麦迪科技12月18日融券偿还0.00股，融券卖出300.00股，按当日收盘价计算，卖出金额 4524.00元；融券余量900.00股，融券余额1.36万元，超过近一年90%分位水平，处于高位。 机构持仓方面，截止2025年9月30日，麦迪科技十大流通股东中，鹏华碳中和主题混合A（016530）退 出十大流通股东之列。 资料显示，苏州麦迪斯顿医疗科技股份有限公司位于江苏省苏州工业园区归家巷222号，成立日期2009 年8月14日，上市日期2016年12月8日，公司主营业务涉及提供临床医疗管理信息系统(CIS)系列应用软 件和临床信息化的整体解决方案。主营业务收入构成为：自制软件40.39%，运维服务31.55%，医疗服 务21.12%，整体解决方案4.60%，外购软硬件1.95%，其他0.40%。 责任编辑：小浪快报 截至9月30日，麦迪科技股东户数3.89万，较上期增加7.17%；人均流通股7864股，较上期减少6.69%。 2025年1月-9月，麦迪科技实现营业收入2.23亿元，同比减少38.13%；归母净利润3426.98万元，同比增 长120.49%。 12月18日，麦迪科技跌0.26%，成交 ...

Company Overview - Suzhou Medisun Medical Technology Co., Ltd. was established on August 14, 2009, and listed on December 8, 2016. The company specializes in providing Clinical Information Management System (CIS) software and overall solutions for clinical informationization [2] - The revenue composition of the company includes self-developed software (40.39%), operation and maintenance services (31.55%), medical services (21.12%), overall solutions (4.60%), purchased software and hardware (1.95%), and others (0.40%) [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 135 million yuan, a year-on-year decrease of 47.24%. However, the net profit attributable to the parent company was 28.33 million yuan, reflecting a year-on-year increase of 137.11% [2] - Since its A-share listing, the company has distributed a total of 71.36 million yuan in dividends, with no dividends distributed in the last three years [3] Stock Market Activity - As of October 24, the company's stock price increased by 2.01%, reaching 15.26 yuan per share, with a total market capitalization of 4.674 billion yuan [1] - The stock has seen a year-to-date increase of 48.44%, with a 4.59% rise over the last five trading days and a 3.11% increase over the last 20 days, although it has decreased by 6.09% over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on March 10, where it recorded a net buy of 31.16 million yuan [1] Shareholder Information - As of June 30, the number of shareholders was 36,300, a decrease of 24.87% from the previous period, while the average circulating shares per person increased by 33.09% to 8,429 shares [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A (016530) is the eighth largest shareholder, holding 2.19 million shares as a new shareholder [3]

Company Overview - Madi Technology's stock price increased by 2.18% on September 25, reaching 14.97 CNY per share, with a trading volume of 1.08 billion CNY and a turnover rate of 2.38%, resulting in a total market capitalization of 45.85 billion CNY [1] - The company has seen a year-to-date stock price increase of 45.62%, with a 1.15% rise over the last five trading days, a 0.34% increase over the last 20 days, and a 6.96% decline over the last 60 days [1] - Madi Technology has appeared on the "Dragon and Tiger List" eight times this year, with the most recent appearance on March 10, where it recorded a net purchase of 31.59 million CNY [1] Financial Performance - For the first half of 2025, Madi Technology reported a revenue of 135 million CNY, a year-on-year decrease of 47.24%, while the net profit attributable to shareholders was 28.33 million CNY, reflecting a year-on-year increase of 137.11% [2] - The company has distributed a total of 71.36 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3] Shareholder Information - As of June 30, 2025, Madi Technology had 36,300 shareholders, a decrease of 24.87% from the previous period, with an average of 8,429 circulating shares per shareholder, an increase of 33.09% [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A (016530) is the eighth largest shareholder, holding 2.19 million shares as a new investor [3] Industry Classification - Madi Technology is classified under the computer software development industry, specifically in vertical application software, and is associated with concepts such as Internet healthcare, assisted reproduction, smart healthcare, small-cap stocks, and private hospitals [2]

Group 1 - The core viewpoint of the news is that Madi Technology's stock has shown significant fluctuations, with a year-to-date increase of 40.56% but a recent decline over the past few trading days [1] - As of September 24, Madi Technology's stock price was 14.45 CNY per share, with a market capitalization of 4.426 billion CNY [1] - The company has seen a net inflow of main funds amounting to 3.1634 million CNY, with large orders accounting for 19.67% of total buying [1] Group 2 - Madi Technology operates in the software development sector, specifically in vertical application software, and is involved in concepts such as Internet healthcare and smart medical services [2] - For the first half of 2025, Madi Technology reported a revenue of 135 million CNY, a year-on-year decrease of 47.24%, while net profit attributable to shareholders increased by 137.11% to 28.3275 million CNY [2] - The company has not distributed any dividends in the last three years, with a total payout of 71.3567 million CNY since its A-share listing [3] Group 3 - As of June 30, 2025, Madi Technology had 36,300 shareholders, a decrease of 24.87%, while the average number of circulating shares per person increased by 33.09% to 8,429 shares [2] - Among the top ten circulating shareholders, Penghua Carbon Neutral Theme Mixed A is the eighth largest, holding 2.1936 million shares as a new shareholder [3]

Company Overview - Madi Technology closed at 15.44 yuan, up 2.93%, with a latest price-to-book ratio of 5.75 and a total market capitalization of 4.729 billion yuan [1] - As of the first quarter of 2025, there is one institutional holder of Madi Technology, holding a total of 49.2201 million shares valued at 0.637 billion yuan [1] Business Operations - Suzhou Madi Technology Co., Ltd. specializes in providing Clinical Information System (CIS) application software and overall solutions for clinical information management [1] - The company's main products include self-developed software, comprehensive solutions, purchased software and hardware, operational and technical services, medical service income, and photovoltaic battery cells [1] Financial Performance - For the first quarter of 2025, Madi Technology reported operating revenue of 63.34 million yuan, a year-on-year decrease of 43.13% [1] - The net profit for the same period was 23.5959 million yuan, showing a year-on-year increase of 138.55% [1] - The sales gross margin stood at 66.10% [1] Industry Comparison - Madi Technology's price-to-earnings (P/E) ratio (TTM) is -17.79, while the industry average is 113.36 [2] - The industry median P/E ratio is 20.17, indicating that Madi Technology's valuation is significantly lower than the industry average [2] - The total market capitalization of Madi Technology is 4.729 billion yuan, compared to the industry average of 11.359 billion yuan [2]